Stock XRAY DENTSPLY SIRONA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials DENTSPLY SIRONA Inc.

Equities

XRAY

US24906P1093

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
30.57 USD +0.72% Intraday chart for DENTSPLY SIRONA Inc. +0.23% -14.11%
Apr. 03 DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 1000 CI
Apr. 03 DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) added to S&P 400 Health Care CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,586 11,444 12,196 6,843 7,540 6,347 - -
Enterprise Value (EV) 1 13,617 13,283 13,952 8,422 9,324 7,895 8,050 7,541
P/E ratio 48.4 x -138 x 29.2 x -7.22 x -57.4 x 23.3 x 19.8 x 15.3 x
Yield 0.66% 0.76% 0.77% 1.57% 1.57% 2.02% 2.16% 2.25%
Capitalization / Revenue 3.12 x 3.42 x 2.87 x 1.74 x 1.9 x 1.59 x 1.53 x 1.47 x
EV / Revenue 3.38 x 3.97 x 3.28 x 2.15 x 2.35 x 1.98 x 1.94 x 1.75 x
EV / EBITDA 15.6 x 19.6 x 14 x 10.9 x 13.5 x 10.7 x 9.82 x 8.3 x
EV / FCF 26.7 x 24.2 x 27.1 x 22.9 x 40.9 x 24.8 x 15.4 x 14.4 x
FCF Yield 3.74% 4.13% 3.69% 4.37% 2.45% 4.03% 6.5% 6.93%
Price to Book 2.46 x 2.31 x 2.41 x 1.8 x 2.29 x 1.9 x 1.79 x 1.72 x
Nbr of stocks (in thousands) 222,414 218,555 218,607 214,912 211,860 207,627 - -
Reference price 2 56.59 52.36 55.79 31.84 35.59 30.57 30.57 30.57
Announcement Date 3/2/20 3/1/21 2/28/22 2/28/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,029 3,342 4,251 3,922 3,965 3,995 4,151 4,319
EBITDA 1 875.3 679 995 776 691 735.1 820.1 908.1
EBIT 1 742.1 537 871 657 571 605.7 687 775.3
Operating Margin 18.42% 16.07% 20.49% 16.75% 14.4% 15.16% 16.55% 17.95%
Earnings before Tax (EBT) 1 345.4 -60 559 -1,055 -175 334.2 425 548.2
Net income 1 262.9 -83 421 -950 -132 236.8 294.7 361.2
Net margin 6.52% -2.48% 9.9% -24.22% -3.33% 5.93% 7.1% 8.36%
EPS 2 1.170 -0.3800 1.910 -4.410 -0.6200 1.313 1.547 1.992
Free Cash Flow 1 509.9 548 515 368 228 318 523.5 522.3
FCF margin 12.66% 16.4% 12.11% 9.38% 5.75% 7.96% 12.61% 12.09%
FCF Conversion (EBITDA) 58.25% 80.71% 51.76% 47.42% 33% 43.26% 63.84% 57.52%
FCF Conversion (Net income) 193.95% - 122.33% - - 134.3% 177.66% 144.63%
Dividend per Share 2 0.3750 0.4000 0.4300 0.5000 0.5600 0.6190 0.6605 0.6867
Announcement Date 3/2/20 3/1/21 2/28/22 2/28/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1,069 1,088 965 1,023 947 983 978 1,028 947 1,012 968.8 1,020 970.2 1,035 1,004
EBITDA 1 246 247 185 210 166 183 161 184 170 173 162.4 189 185 196.5 194.7
EBIT 1 216 217 153 180 139 154 133 160 135 143 130.4 156.7 152.4 164.1 156.8
Operating Margin 20.21% 19.94% 15.85% 17.6% 14.68% 15.67% 13.6% 15.56% 14.26% 14.13% 13.46% 15.37% 15.7% 15.86% 15.61%
Earnings before Tax (EBT) 1 138 138 83 91 -1,241 8 -28 46 -250 57 59.92 89.6 88.28 96.26 77.03
Net income 1 103 102 65 73 -1,077 -15 -19 86 -266 67 46 63.39 62.01 68.42 60.83
Net margin 9.64% 9.38% 6.74% 7.14% -113.73% -1.53% -1.94% 8.37% -28.09% 6.62% 4.75% 6.21% 6.39% 6.61% 6.06%
EPS 2 0.4700 0.4700 0.3000 0.3400 -5.010 -0.0700 -0.0900 0.4000 -1.250 0.3200 0.2543 0.3843 0.3614 0.4214 0.3575
Dividend per Share 2 0.1100 0.1100 0.1250 0.1250 0.1250 0.1250 0.1400 0.1400 0.1250 0.1400 0.1600 0.1600 0.1600 0.1600 0.1600
Announcement Date 11/4/21 2/28/22 5/10/22 11/7/22 11/14/22 2/28/23 5/3/23 8/2/23 11/2/23 2/29/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,031 1,839 1,756 1,579 1,784 1,548 1,703 1,194
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.177 x 2.708 x 1.765 x 2.035 x 2.582 x 2.106 x 2.077 x 1.315 x
Free Cash Flow 1 510 548 515 368 228 318 524 522
ROE (net income / shareholders' equity) 10.8% 7.83% 12.6% 10.3% 11% 12.8% 14.7% 16%
ROA (Net income/ Total Assets) 6.36% 4.39% 6.8% 5.35% 5.18% 4.18% 5.22% -
Assets 1 4,132 -1,890 6,192 -17,741 -2,547 5,659 5,642 -
Book Value Per Share 2 23.00 22.70 23.20 17.70 15.50 16.10 17.10 17.80
Cash Flow per Share 2 2.820 2.900 2.980 2.400 1.780 2.550 3.040 3.500
Capex 1 123 87 142 149 149 185 172 171
Capex / Sales 3.05% 2.6% 3.34% 3.8% 3.76% 4.63% 4.14% 3.95%
Announcement Date 3/2/20 3/1/21 2/28/22 2/28/23 2/29/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for DENTSPLY SIRONA Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
30.57 USD
Average target price
36.47 USD
Spread / Average Target
+19.30%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
DENTSPLY SIRONA INC. Stock DENTSPLY SIRONA Inc.
-14.11% 6.35B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. XRAY Stock
  4. Financials DENTSPLY SIRONA Inc.